{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"AlphaNooner by AdvisorShares","title":"AlphaNooner - Cannabis Rescheduling, Psychedelic Medicine & the Road to 2027","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a867a22e\"></iframe>","width":"100%","height":180,"duration":1818,"description":"Federal cannabis rescheduling remains on track, but investors are still waiting for the next official update. What could come next for cannabis stocks, and which developments could shape the industry heading into 2027?\nOn this episode of AlphaNooner, AdvisorShares' Dan Ahrens joins Mackenzie Peterson to discuss the outlook for cannabis reform, the latest developments at Trulieve and Glass House Brands, changes to hemp regulation, and growing momentum in psychedelic medicine.\nFrom federal policy to company-specific catalysts and FDA developments, Dan breaks down what matters for investors and what he's watching through year-end.\nAlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shaping what comes next.\nWatch the full video on YouTube: https://www.youtube.com/watch?v=fWo2KSU9KtQ\nFollow AdvisorShares (@advisorshares) on YouTube, X, LinkedIn, Instagram and Facebook.","thumbnail_url":"https://img.transistorcdn.com/YTg3I0tYDY_pVKIr6ftqR4QH-crMUIYU9Ptau8tTyEM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zOGUw/NDFhNmI0NGM3NGY5/OGU0ODBkZmNlOWMx/NjRjNy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}